| 1201/2088 | US=20 / Odontologia Scully C. Odontogenic cysts and tumours. In: ___. Oral and maxillofacial medicine: the basis of diagnosis and treatment. 2nd ed. Edinburgh: Churchill Livingstone, 2008. p. 249-59. ISBN 978-0-443-06818-8. CISTOS ODONTOGENICOS; TUMORES ODONTOGENICOS; CISTOS DE ERUPCAO; DENTIGERO; CISTOS INFLAMATORIOS; TUMOR ODONTOGENICO QUERATOCISTICO; ODONTOGENICO CERATOCISTO; CISTO PRIMORDIAL; TUMORES ODONTOGENICOS; ODONTOMES; ESMALTE PEROLAS; DENTINOMA; CEMENTOMA; DENS INVAGINATUS; EVAGINATUS TOCAS; ODONTOME GEMINADO; AMELOBLASTOMA; MIXOMA ODONTOGENICO; TUMOR ODONTOGENICO ADENOMATOIDE; FIBROMA ODONTOGENICO; FIBROMA AMELOBLASTICO; AMELOBLASTICO FIBRO-SARCOMA |
| 1202/2088 | US=21 / Biol/Mol Giavazzi R, Bonezzi K, Taraboletti G. Microtubule targeting agents and the tumor vasculature. In: Fojo T. The role of microtubules in cell biology, neurobiology, and oncology. New Jersey: Springer, 2008. p. 519-30. (Cancer Drug Discovery and Development) ISBN 978-1-58829-294-0. AGENTES DE MICROTUBULOS SEGMENTACAO EA VASCULARIZACAO DO TUMOR; INIBIDORES DA ANGIOGENESE; AGENTE DE RUPTURA VASCULAR; CELULAS ENDOTELIAIS; VASCULATURA TUMORAL; TERAPEUTICA DE COMBINACAO |
| 1203/2088 | US=23 / Biol/Mol Read A, Donnai D. O câncer é genético?. In: ___. Genética clínica: uma nova abordagem. Porto Alegre: Artmed, 2008. p. 293-328. ISBN 85-3631190-6. CANCER; EVOLUCAO DO CANCER; HISTORICO FAMILIAR; ONCOGENES; GENES SUPRESSORES DE TUMOR; CANCER COLORRETAL HEREDITARIO SEM POLIPOSE; DESENVOLVIMENTO DO CANCER; EPIGENETICA NO CANCER; CANCERES FAMILIARES DE MAMA; CANCERES FAMILIARES DE COLORRETAL |
| 1204/2088 | US=26 / Patologia Stelow EB, Mills SE. Soft tissue tumors. In: ___. Biopsy interpretation of the upper aerodigestive tract and ear. Philadelphia: J B Lippincott, 2008. p. 174-248. (Biopsy Interpretation Series) ISBN 978-0-7817-9310-0. TUMORES DE TECIDOS MOLES; FIBROBLASTICA; TUMORES MIOFIBROBLASTICAS; FIBROSSARCOMA; TUMORES MIOGENICA; LEIOMIOMAS; LEIOMIOSSARCOMA; RABDOMIOMA; RABDOMIOSSARCOMA; TUMORES VASCULARES; HEMANGIOMA; LINFANGIOMA CAVERNOSO; ANGIOFIBROMA; GLOMANGIOPERICYTOMA; TUMOR GLOMICO; ANGIOSSARCOMA; TUMORES DE GORDURA; LIPOSSARCOMA; SARCOMA SYNOVIL; ALVEOLAR SARCOMA PARTE SOLF; CORDOMA; CHONDROI E TUMORES OSSEOS |
| 1205/2088 | US=27 / Radioterapia Gajjar A. Pediatric brain tumors: chemotherapy perspective. In: Chin LS, Regine WF. Principles and practice of steriotatic radiosurgery. New York: Springer, 2008. p. 351-4. ISBN 978-0-387-71069-3. TUMORES CEREBRAIS PEDIATRICOS; TUMORES CEREBRAIS PEDIATRICOS. QUIMIOTERAPIA; EPENDIMOMA; GLIOMA DE BAIXO GRAU; MEDULOBLASTOMA TUMOR NEUROECTODERMICO PRIMITIVO; CRANIOFARINGIOMA |
| 1206/2088 | US=27 / Radioterapia Milker-Zabel S, Kwok Y, Debus J. Skull base tumors. In: Chin LS, Regine WF. Principles and practice of steriotatic radiosurgery. New York: Springer, 2008. p. 383-92. ISBN 978-0-387-71069-3. BASE DE TUMORES DO CRANIO; FOSSA CRANIANA ANTERIOR; TUMOR DA FOSSA POSTERIOR DO CRANIO; TUMOR FOSSA CRANIANA MEDIA |
| 1207/2088 | US=28 / Biol/Mol Aiyer AR, Varner JA. The role of integrins in tumor angiogenesis. In: Teicher BA, Ellis LM. Antiangiogenic agents in cancer therapy. 2 ed. Houston: Humana Press, 2008. p. 49-71. ISBN 978-1-58829-870-6. INTEGRINAS NA ANGIOGENESE TUMORAL; INTEGRINA; GENESE; APOPTOSE; CELULAS ENDOTELIAIS; PERICYTE |
| 1208/2088 | US=28 / Biol/Mol Dudley AC, Klagsbrun M. Tumor endothelial cell abnormalities. In: Teicher BA, Ellis LM. Antiangiogenic agents in cancer therapy. 2 ed. Houston: Humana Press, 2008. p. 73-84. ISBN 978-1-58829-870-6. TUMORAIS ENDOTELIAIS ANORMALIDADES CELULARES; TUMOR; CELULAS ENDOTELIAIS; ANGIOGENESE; ANORMALIDADES CROMOSSOMICAS; RESISTENCIA A DROGAS; ESTROMA TUMORAL; P53 |
| 1209/2088 | US=28 / Biol/Mol Bagley RG. Endothelial precursor cells. In: Teicher BA, Ellis LM. Antiangiogenic agents in cancer therapy. 2 ed. Houston: Humana Press, 2008. p. 99-115. ISBN 978-1-58829-870-6. CELULAS PRECURSORAS ENDOTELIAIS; VASCULATURES; TUMOR; ANGIOGENESE; CD133 |
| 1210/2088 | US=28 / Urologia Crispen PL, Chawla SN, Uzzo RG. Active surveillance of localized renal tumors. In: Bukowski RM, Novick AC. Clinical management of renal tumors. New Jersey: Humana Press, 2008. p. 159-76. ISBN 978-1-58829-251-3. |
| 1211/2088 | US=28 / Urologia Crispen PL, Chawla SN, Uzzo RG. Active surveillance of localized renal tumors. In: Bukowski RM, Novick AC. Clinical management of renal tumors. New Jersey: Humana Press, 2008. p. 159-76. ISBN 978-1-58829-251-3. |
| 1212/2088 | US=28 / Urologia Bukowski RM. Adjuvant therapy of renal cell carcinoma. In: Bukowski RM, Novick AC. Clinical management of renal tumors. New Jersey: Humana Press, 2008. p. 293-306. ISBN 978-1-58829-251-3. TERAPIA ADJUVANTE DO CARCINOMA DE CELULAS RENAIS; CARCINOMA DE CELULAS RENAIS; VACINA TUMOR AUTOLOGO; ADJUVANTES ENSAIOS DE CITOCINAS |
| 1213/2088 | US=28 / Biol/Mol Kabayashi H, DeBush LM, Lin PC. Angiopoietin/Tie2 signaling regulates tumor angiogenesis. In: Teicher BA, Ellis LM. Antiangiogenic agents in cancer therapy. 2 ed. Houston: Humana Press, 2008. p. 171-87. ISBN 978-1-58829-870-6. ANGIOPOIETINA; AMARRAR; ANGIOGENESE TUMORAL; VEGF; CANCER; METASTASE |
| 1214/2088 | US=28 / Biol/Mol Nagy JA, Fu Y, Dvorak AM, Dvorak HF. Tumor blood vessels. In: Teicher BA, Ellis LM. Antiangiogenic agents in cancer therapy. 2 ed. Houston: Humana Press, 2008. p. 205-24. ISBN 978-1-58829-870-6. VEGF-A; VASOS SANGUINEOS TUMORAIS; ANGIOGENESE; ARTERIOGENESE; VENOGENESIS |
| 1215/2088 | US=28 / Biol/Mol Jain RK, Batchelor TT, Duda DG, Willett CG. Normalization of tumor vasculature and microenvironment. In: Teicher BA, Ellis LM. Antiangiogenic agents in cancer therapy. 2 ed. Houston: Humana Press, 2008. p. 261-76. ISBN 978-1-58829-870-6. |
| 1216/2088 | US=28 / Biol/Mol Mendoza E, Burd R, Wachsberger P, Dicker AP. Normalization of tumor vasculature and improvement of radiation response by antiangiogenic agents. In: Teicher BA, Ellis LM. Antiangiogenic agents in cancer therapy. 2 ed. Houston: Humana Press, 2008. p. 311-21. ISBN 978-1-58829-870-6. ANGIOGENESE; AGENTES ANTI-ANGIOGENICOS; CANCER; CLINICO; PRE-CLINICO; NORMALIZACAO; TUMOR; RESPOSTA RADIACAO; TERAPIA DE RADIACAO; OXIGENACAO DO TUMOR; VASCULATURA |
| 1217/2088 | US=23 / Câncer Lumachi F, Basso SMM, Basso U. Breast cancer recurrence: role of serum tumor markers CEA and CA 15-3. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 109-15. ISBN 978-1-4020-8368-6. CANCER DE MAMA; CANCER DE MAMA RECORRENTE; PAPEL DO SORO; MARCADORES TUMORAIS; CEA; CA 15-3; ANTIGENO CARCINOEMBRIONARIO |
| 1218/2088 | US=23 / Câncer Zehentner BK. Breast cancer patients before, during or after treatment: circulating tumor cells in peripheral blood detected by multigene real-time reverse transcriptase-polymerase chain reaction. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 117-23. ISBN 978-1-4020-8368-6. CANCER DE MAMA; CELULAS TUMORAIS CIRCULANTES; SANGUE PERIFERICO; REACAO MULTIGENICA EM TEMPO REAL; REACAO EM CADEIA DA POLIMERASE-TRANSCRIPTASE REVERSA |
| 1219/2088 | US=23 / Câncer Tan PH, Tse GMK, Yip GWC, Bay BH. Phyllodes tumours of the breast: the role of immunohistochemistry in diagnosis. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 251-62. ISBN 978-1-4020-8368-6. CANCER DE MAMA; TUMOR PHYLLODES; IMUNOHISTOQUIMICA; CARACTERISTICAS CLINICO-PATOLOGICAS |
| 1220/2088 | US=23 / Câncer Esposito NN, Dabbs DJ. Phyllodes tumours of the breast: prognostic assessment using immunohistochemistry. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 263-73. ISBN 978-1-4020-8368-6. CANCER DE MAMA; TUMOR PHYLLODES; IMUNOHISTOQUIMICA; AVALIACAO PROGNOSTICA; MARCADORES DE PROLIFERACAO CELULAR; GENES SUPRESSORES DE TUMOR; P53; RECEPTORES DE ESTEROIDES; PROTEINAS; FATORES DE CRESCIMENTO EPIDERMICO; HER-2/NEU; ANALISE CROMOSSOMICA; ANALISE MOLECULAR; ANALISE HISTOPATOLOGICA |